Ledyard, CT, United States of America

Matthew David Wessel

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew David Wessel. Retrieved from https://idiyas.com/inventor/matthew-david-wessel-w3o27kfv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 51(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Matthew David Wessel - Innovative Inventor from Ledyard, CT

Introduction: Matthew David Wessel is a talented inventor hailing from Ledyard, CT, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Matthew David Wessel holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Matthew David Wessel has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Matthew David Wessel has collaborated with top inventors, patent attorneys, and companies to bring his ideas to life, fostering a culture of innovation and creativity in the process.

Conclusion: Matthew David Wessel's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…